GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Mental disorders like depression and anxiety are characterized by a variety of different symptoms, and individuals receiving the same diagnosis may experience different combinations of those symptoms.

For decades, one of the greatest challenges to treating neurological disorders like attention-deficit/hyperactivity disorder is that its symptoms often resemble those of several other conditions.

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

Researchers recently discovered that eight different psychiatric conditions share a common genetic basis. A new study has now honed in on some of those shared genetic variants to understand their ...

Could hyperbaric oxygen treat PTSD, depression, and anxiety? New evidence suggests that this treatment may rewire the ...

Social media has transformed the way people interact with each other and the world. Across the globe, researchers have documented political, social, emotional, and even health implications related to ...

Researchers examined 54 clinical trials to see if cannabis helps treat mental health or addiction issues. They found minimal proof of benefit, alongside a higher risk of mild side effects like ...